The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
A Re-Evaluation of the Frequency of CD8+ T Cells Specific for EBV in Healthy Virus Carriers
Abstract
EBV is a gammaherpesvirus that can establish both nonproductive (latent) and productive (lytic) infections within the cells of its host. Although T cell responses to EBV latent proteins have been well characterized, little is known about the importance of responses to lytic proteins in long term virus carriers. Here we have compared the frequencies of CD8+ T cells specific for EBV latent and lytic Ags in healthy virus carriers, using three techniques: limiting dilution analysis, enzyme-linked immunospot assay, and FACS staining with tetrameric MHC-peptide complexes. T cells specific for EBV lytic protein epitopes were readily detectable in all donors and were usually more abundant than those specific for latent epitopes. We infer that direct T cell control of viral replicative lesions is maintained in long term carriers of EBV and is an important component of the immune response to this virus. Estimates of CD8+ T cell frequencies varied considerably according to methodology; values obtained from MHC-peptide tetramer staining were, on the average, 4.4-fold higher than those obtained from enzyme-linked immunospot assays, which were, in turn, on the average, 5.3-fold higher than those obtained from limiting dilution analysis. Tetramer staining showed that as many as 5.5% circulating CD8+ T cells in a virus carrier were specific for a single EBV lytic protein epitope. Such values are much greater than previously imagined and illustrate how antigenic challenge from a persistent herpesvirus can influence the composition of the host’s CD8+ T cell pool.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Phenotypic Analysis of Antigen-Specific T Lymphocytes
Altman, J. D., Moss, P. A. H., Goulder, P. J. R., Barouch, D. H., McHeyzer-Williams, M. G., Bell, J. I., McMichael, A. J., & Davis, M. M. (1996) · Science · doi:10.1126/science.274.5284.94 · Cited by 3,544 · cited 2×
“Soluble MHC-peptide tetramers were produced using a method similar to that described previously (16).”
MethodSelf-citationRickinson, A. (2001) · Virus Research · doi:10.1016/s0168-1702(01)00436-1 · Cited by 2,179
Self-citationCounting Antigen-Specific CD8 T Cells: A Reevaluation of Bystander Activation during Viral Infection
Murali-Krishna, K., Altman, J. D., Suresh, M., Sourdive, D. J. D., Zajac, A. J., Miller, J. D., Slansky, J., & Ahmed, R. (1998) · Immunity · doi:10.1016/s1074-7613(00)80470-7 · Cited by 1,943
Epstein-Barr virus and its replication
Kieff, E. D. (1996) · Medical Entomology and Zoology · Cited by 1,627
Phenotypic and functional separation of memory and effector human CD8+ T cells
Hamann, D., Baars, P. A., Rep, M. H. G., Hooibrink, B., Kerkhof-Garde, S. R., Klein, M. R., & Lier, R. A. W. V. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.9.1407 · Cited by 1,366
Rooney, C. M., Ng, C. Y. C., Loftin, S., Smith, C. A., Li, C., Krance, R. A., Brenner, M. K., Heslop, H. E., Rooney, C. M., Brenner, M. K., et al. (1995) · The Lancet · doi:10.1016/s0140-6736(95)91150-2 · Cited by 1,173
Papadopoulos, E. B., Ladanyi, M., Emanuel, D., Mackinnon, S., Boulad, F., Carabasi, M. H., Castro-Malaspina, H., Childs, B. H., Gillio, A. P., Small, T. N., et al. (1994) · New England Journal of Medicine · doi:10.1056/nejm199404283301703 · Cited by 1,043
T Cell Activation Determined by T Cell Receptor Number and Tunable Thresholds
Viola, A., & Lanzavecchia, A. (1996) · Science · doi:10.1126/science.273.5271.104 · Cited by 1,023
Loss of CD45R and gain of UCHL1 reactivity is a feature of primed T cells.
Akbar, A. N., Terry, L., Timms, A., Beverley, P. C., & Janossy, G. (1988) · The Journal of Immunology · doi:10.4049/jimmunol.140.7.2171 · Cited by 921
Callan, M. F. C., Tan, L., Annels, N., Ogg, G. S., Wilson, J. D. K., O'Callaghan, C. A., Steven, N., McMichael, A. J., & Rickinson, A. B. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.9.1395 · Cited by 892
Self-citationMassive Expansion of Antigen-Specific CD8+ T Cells during an Acute Virus Infection
Butz, E. A., & Bevan, M. J. (1998) · Immunity · doi:10.1016/s1074-7613(00)80469-0 · Cited by 769
Epstein–Barr Virus Replication in Oropharyngeal Epithelial Cells
Sixbey, J. W., Nedrud, J. G., Raab-Traub, N., Hanes, R. A., & Pagano, J. S. (1984) · New England Journal of Medicine · doi:10.1056/nejm198405103101905 · Cited by 723
Rapid Effector Function in CD8+ Memory T Cells
Lalvani, A., Brookes, R., Hambleton, S., Britton, W. J., Hill, A. V. S., & McMichael, A. J. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.6.859 · Cited by 644
Self-citationExpression of Interleukin-10 Activity by Epstein-Barr Virus Protein BCRF1
Hsu, D.-H., Malefyt, R. D. W., Fiorentino, D. F., Dang, M.-N., Vieira, P., deVries, J., Spits, H., Mosmann, T. R., & Moore, K. W. (1990) · Science · doi:10.1126/science.2173142 · Cited by 535
Murray, R. J., Kurilla, M. G., Brooks, J. M., Thomas, W. A., Rowe, M., Kieff, E., & Rickinson, A. B. (1992) · The Journal of experimental medicine · doi:10.1084/jem.176.1.157 · Cited by 499
Self-citationTierney, R. J., Steven, N., Young, L. S., & Rickinson, A. B. (1994) · Journal of Virology · doi:10.1128/jvi.68.11.7374-7385.1994 · Cited by 482
Self-citationBrooks, L., Yao, Q. Y., Rickinson, A. B., & Young, L. S. (1992) · Journal of Virology · doi:10.1128/jvi.66.5.2689-2697.1992 · Cited by 480
Self-citationSpertini, O., Luscinskas, F. W., Kansas, G. S., Munro, J. M., Griffin, J. D., Gimbrone, M. A., & Tedder, T. F. (1991) · The Journal of Immunology · doi:10.4049/jimmunol.147.8.2565 · Cited by 394
Khanna, R., Burrows, S. R., Kurilla, M. G., Jacob, C. A., Misko, I. S., Sculley, T. B., Kieff, E., & Moss, D. J. (1992) · The Journal of experimental medicine · doi:10.1084/jem.176.1.169 · Cited by 384
Limiting Dilution Analysis of Cells in the Immune System
Lefkovits, I., & Waldmann, H. (1979) · Medical Entomology and Zoology · Cited by 377
Deacon, E. M., Pallesen, G., Niedobitek, G., Crocker, J., Brooks, L., Rickinson, A. B., & Young, L. S. (1993) · The Journal of experimental medicine · doi:10.1084/jem.177.2.339 · Cited by 356
Self-citationThree pathways of Epstein-Barr virus gene activation from EBNA1-positive latency in B lymphocytes
Rowe, M., Lear, A. L., Croom-Carter, D., Davies, A. H., & Rickinson, A. B. (1992) · Journal of Virology · doi:10.1128/jvi.66.1.122-131.1992 · Cited by 351
Self-citationSteven, N. M., Annels, N. E., Kumar, A., Leese, A. M., Kurilla, M. G., & Rickinson, A. B. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.185.9.1605 · Cited by 350
Self-citationWaldmann, T. A. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)49895-x · Cited by 345
Hara, T., Fu, S. M., & Hansen, J. A. (1985) · The Journal of experimental medicine · doi:10.1084/jem.161.6.1513 · Cited by 278
Burrows, S. R., Khanna, R., Burrows, J. M., & Moss, D. J. (1994) · The Journal of experimental medicine · doi:10.1084/jem.179.4.1155 · Cited by 271
Maggi, E., Giudizi, M. G., Biagiotti, R., Annunziato, F., Manetti, R., Piccinni, M. P., Parronchi, P., Sampognaro, S., Giannarini, L., Zuccati, G., et al. (1994) · The Journal of experimental medicine · doi:10.1084/jem.180.2.489 · Cited by 267
McMichael, A. J., & O'Callaghan, C. A. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.9.1367 · Cited by 263
Self-citationHLA-A11 Epitope Loss Isolates of Epstein-Barr Virus From a Highly A11 + Population
de Campos-Lima, P.-O., Gavioli, R., Zhang, Q.-J., Wallace, L. E., Dolcetti, R., Rowe, M., Rickinson, A. B., & Masucci, M. G. (1993) · Science · doi:10.1126/science.7682013 · Cited by 252
Self-citationBorysiewicz, L. K., Hickling, J. K., Graham, S., Sinclair, J., Cranage, M. P., Smith, G. L., & Sissons, J. G. (1988) · The Journal of experimental medicine · doi:10.1084/jem.168.3.919 · Cited by 246
An Epstein-Barr virus-specific cytotoxic T cell epitope in EBV nuclear antigen 3 (EBNA 3).
Burrows, S. R., Sculley, T. B., Misko, I. S., Schmidt, C., & Moss, D. J. (1990) · The Journal of experimental medicine · doi:10.1084/jem.171.1.345 · Cited by 170
Steven, N. M., Leese, A. M., Annels, N. E., Lee, S. P., & Rickinson, A. B. (1996) · The Journal of experimental medicine · doi:10.1084/jem.184.5.1801 · Cited by 168
Self-citationT cell response to Epstein-Barr virus transactivators in chronic rheumatoid arthritis.
Scotet, E., David-Ameline, J., Peyrat, M. A., Moreau-Aubry, A., Pinczon, D., Lim, A., Even, J., Semana, G., Berthelot, J. M., Breathnach, R., et al. (1996) · The Journal of experimental medicine · doi:10.1084/jem.184.5.1791 · Cited by 167
Moss, P. A. H., Rowland‐Jones, S., Frodsham, P., McAdam, S., Giangrande, P. L. F., McMichael, A. J., & Bell, J. I. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.13.5773 · Cited by 157
Self-citationGavioli, R., Kurilla, M. G., de Campos-Lima, P. O., Wallace, L. E., Dolcetti, R., Murray, R. J., Rickinson, A. B., & Masucci, M. G. (1993) · Journal of Virology · doi:10.1128/jvi.67.3.1572-1578.1993 · Cited by 157
Self-citationAn Epstein-Barr virus-associated superantigen.
Sutkowski, N., Palkama, T., Ciurli, C., Sékaly, R., Thorley‐Lawson, D. A., & Huber, B. T. (1996) · The Journal of Experimental Medicine · doi:10.1084/jem.184.3.971 · Cited by 136
Epstein-Barr virus gene expression in P3HR1-superinfected Raji cells
Biggin, M. D., Bodescot, M., Perricaudet, M., & Farrell, P. J. (1987) · Journal of Virology · doi:10.1128/jvi.61.10.3120-3132.1987 · Cited by 133
Bogedain, C., Wolf, H. J., Modrow, S., Stuber, G., & Jilg, W. (1995) · Journal of Virology · doi:10.1128/jvi.69.8.4872-4879.1995 · Cited by 122
Cochet, C., Martel-Renoir, D., Grunewald, V., Bosq, J., Cochet, G., Schwaab, G., Bernaudin, J., & Joab, I. (1993) · Virology · doi:10.1006/viro.1993.1597 · Cited by 109
Tigges, M. A., Koelle, D. M., Hartog, K., Sekulovich, R. E., Corey, L., & Burke, R. L. (1992) · Journal of Virology · doi:10.1128/jvi.66.3.1622-1634.1992 · Cited by 101
d’Angeac, A. D., Monier, S., Pilling, D., Travaglio‐Encinoza, A., Reme, T. X., & Salmon, M. (1994) · European Journal of Immunology · doi:10.1002/eji.1830240707 · Cited by 96
Five new cytotoxic T cell epitopes identified within Epstein-Barr virus nuclear antigen 3
Burrows, S. R., Gardner, J., Khanna, R., Steward, T. W., Moss, D. J., Rodda, S. J., & Suhrbier, A. (1994) · Journal of General Virology · doi:10.1099/0022-1317-75-9-2489 · Cited by 96
Characterization of two Epstein‐Barr virus epitopes restricted by HLA‐B7
Hill, A. B., Worth, A. J. J., Elliott, T. J., Rowland‐Jones, S., Brooks, J. M., Rickinson, A. B., & McMichael, A. J. (1995) · European Journal of Immunology · doi:10.1002/eji.1830250105 · Cited by 63
Self-citation
Cited by
Cohen, J. I. (2000) · New England Journal of Medicine · doi:10.1056/nejm200008173430707 · Cited by 1,636
(2012) · SpringerReference · doi:10.1007/springerreference_301423 · Cited by 1,192
Epstein-Barr virus: exploiting the immune system
Thorley-Lawson, D. A. (2001) · Nature Reviews Immunology · doi:10.1038/35095584 · Cited by 939
Human memory T cells: generation, compartmentalization and homeostasis
Farber, D. L., Yudanin, N. A., & Restifo, N. P. (2014) · Nature Reviews Immunology · doi:10.1038/nri3567 · Cited by 897
HIV-specific CD8(+) T cells produce antiviral cytokines but are impaired in cytolytic function
Appay, V., Nixon, D. F., Donahoe, S. M., Gillespie, G. M. A., Dong, T., King, A., Ogg, G. S., Spiegel, H. M. L., Conlon, C., Spina, C. A., et al. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.1.63 · Cited by 871
Self-citation
Metadata
- Authors
- Tan, L. C., Gudgeon, N., Annels, N. E., Hansasuta, P., O’Callaghan, C. A., Rowland-Jones, S., McMichael, A. J., Rickinson, A. B., & Callan, M. F. C.
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 1999-02-01
- Volume
- 162
- Issue
- 3
- Pages
- 1827-1835
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W2145928191
- Cited by
- 499
- References
- 43
- FWCI
- 27.80
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.